TC
LLY icon

TFR Capital’s Eli Lilly LLY Stock Holding History

TFR Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Sell
4,709
-877
-16% -$896K 1.59% 14
2026
Q1 		$5.14M Buy
5,586
+249
+5% +$252K 1.58% 17
2025
Q4 		$5.74M Buy
5,337
+332
+7% +$317K 1.9% 14
2025
Q3 		$3.82M Buy
5,005
+72
+1% +$53.6K 1.28% 17
2025
Q2 		$3.85M Buy
4,933
+166
+3% +$129K 1.39% 16
2025
Q1 		$3.94M Buy
4,767
+676
+17% +$562K 1.64% 14
2024
Q4 		$3.16M Buy
+4,091
New +$3.39M 1.57% 17

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TFR Capital's LLY Position: Q2 2026 in Review

TFR Capital reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $896K and leaving 4,709 shares worth $5.65M. The position accounts for 1.59% of the portfolio, ranked #14.

TFR Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.74M in Q4 2025. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TFR Capital held 4,709 shares of Eli Lilly worth $5.65M as of Q2 2026.
  • TFR Capital sold 877 Eli Lilly shares in Q2 2026, an estimated $896K.
  • Eli Lilly made up 1.59% of TFR Capital's portfolio in Q2 2026, its #14 holding.
  • TFR Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • TFR Capital's Eli Lilly position peaked at $5.74M in Q4 2025.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TFR Capital's 13F filing for Q2 2026, filed 6 Aug 2026.